Christine N. Spencer
Parker Institute for Cancer Immunotherapy(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune cells in cancer, Gut microbiota and health, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients(2017)4,526 cited
- → B cells and tertiary lymphoid structures promote immunotherapy response(2020)2,549 cited
- → The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy(2018)1,328 cited
- → Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response(2021)834 cited
- → Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma(2018)810 cited
- → Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis(2018)651 cited
- → Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade(2021)398 cited
- → Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial(2018)286 cited
- → Hallmarks of Resistance to Immune-Checkpoint Inhibitors(2022)122 cited
- → Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.(2014)76 cited